Gene Query: ANKMY1

Dataset Description Geneva Score
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 17.79
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 14.13
Transcriptome analysis of human lung epithelial cells 13.35
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 11.28
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.56
The Human Testis Cell Atlas via Single-cell RNA-seq 8.8
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 7.74
The conserved transcriptional landscapes in human spermatogenesis 7.7
TT-Seq captures the human transient transcriptome 7.33
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.71
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 6.45
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.34
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.25
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.25
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.78
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 4.69
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 4.69
Universal alternative splicing of noncoding exons 4.59
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.54
RNA-Seq in PWS iPSC-derived neurons 4.41
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 4.39
Characterization of human ILC2 subsets 3.77
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.7
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.63
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 3.61
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 3.57
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.53
Targeted enhancer activation by a subunit of the integrator complex 3.53
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.38
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.38
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.35
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 3.32
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 3.32
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 3.26
BCL11B 3.24
NRDE2 negatively regulates nuclear exosome functions 3.04
NR2F2 study 2.92
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.92
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.86
Reassessment of Exosome Composition 2.81
The evolution of N6-methyladenosine in primates 2.78
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.69
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 2.63
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.6
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 2.55
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.55
Modulation of nonsense-mediated decay by rapamycin 2.52
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.51
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 2.45
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.45
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 2.4
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.36
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.34
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.32
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.26
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.24
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.24
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.22
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.22
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.18
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 2.12
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 2.12
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 2.12
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 2.11
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 2.09
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.06
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 2.04
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 2.04
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.03
Recovery and analysis of nascent RNA 2.03
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.02
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.02
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.95
RNA-sequencing 1.9
RNA sequencing of GlyH-101-treated MCF-7 cell line 1.84
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 1.75
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.75
Glioblastoma stem cells infected by ZIKA virus 1.74
Targeting MTHFD2 in Acute Myeloid Leukemia 1.71
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 1.7
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 1.7
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.65
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.64
RNA polymerase in pre-B-ALL cell lines 1.61
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 1.6
Identification of global regulators of T-helper cell lineage specification 1.6
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.6
Gene expression in GBM with Cav3.2 inhibition 1.6
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.59
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.58
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 1.55
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 1.54
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 1.53
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.52
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.51
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.51
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.46
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.46
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.45
Non-coding regions are the main source of tumor-specific antigens [human] 1.41
Non-coding regions are the main source of tumor-specific antigens 1.41
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.41
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.4
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.4
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 1.39
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 1.38
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 1.38
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 1.38
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.32
Exploring ILF2 regulatory genes by next-generation sequencing 1.32
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.31
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.31
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.3
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.3
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 1.25
LncRNA-GAS5 negative regulation of YAP-target genes expression 1.25
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.25
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 1.24
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.23
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.23
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.21
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.21
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.21
The landscape of alternative splicing in aggressive prostate cancers 1.21
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.21
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 1.19
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 1.19
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 1.19
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.18
PTHrP overexpression in MCF7 cells 1.17
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 1.17
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.16
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.16
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.16
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.15
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.15
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 1.15
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 1.15
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 1.14
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 1.14
Altering cancer transcriptomes using epigenomic inhibitors 1.14
Gene expression activation in CLL mediated by MSCs contact 1.14
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.13
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.13
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.13
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 1.13
Genome-wide discovery of human splicing branchpoints [RNAse] 1.12
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.09
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.07
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.06
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.06
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.06
Gene expression changes associated with resistance to tagraxofusp (SL-401) 1.06
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 1.05
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 1.05
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 1.05
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.05
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 1.04
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.03
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.03
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 1.03
Global Mapping of Human RNA-RNA Interactions 1.03
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 1.02
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.01
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.0
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.0
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 0.99
LncRNA expression profiling of ischemic stroke patients 0.99
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.99
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.98
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.98
RNA-Seq and expression data from human adipose tissue 0.98
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.98
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.97
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.97
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.97
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.97
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 0.97
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 0.96
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.96
Single-cell analysis of adult human ovary using 10X genomics 0.95
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.95
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.95
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.95
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 0.94
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.94
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.94
Intrahepatic MAIT cell gene expression revealed by RNA-seq 0.94
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 0.93
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.92
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 0.92
Intron retention induced by microsatellite expansions as a disease biomarker. 0.91
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.91
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.91
HEK293 Heat-shock experiment 0.91
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 0.91
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 0.89
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.88
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.88
RNA-Seq with and without RNase treatment in PCa cell lines 0.88
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 0.87
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.87
Identification of global XBP1s target gene expression in human prostate cancer cells 0.87
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.87
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.87
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.86
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.86
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.86
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.86
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.86
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.86
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.85
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.85
MYC dependent mRNA translation shapes gene expression and cell biology 0.85
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.85
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.85
Transciptomic profiling of human fetal lung samples 0.85
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.84
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.84
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.84
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.84
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.83
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.83
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.83
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 0.82
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.82
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 0.82
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.82
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.81
Transcriptome of EBV-infected gastric cancer cell lines 0.8
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.8
Proliferation-correlated expression 0.8
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.79
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.79
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.79
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.79
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.78
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.77
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 0.75
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.75
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.75
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.75
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.75
RNA-seq melanoma 0.74
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.74
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.74
Transcriptome of activated human and mouse MAIT cells 0.74
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.74
Transcriptome Profiling of Human Primary Monocytes 0.74
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 0.74
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.73
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.73
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 0.73
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 0.73
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.72
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.72
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.72
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.72
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.72
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.72
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.72
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.71
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 0.71
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 0.71
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.7
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 0.7
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 0.7
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.69
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.69
RNAseq Analysis in glioblastoma cells treated with Mepazine 0.69
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.68
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.67
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.67
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.67
Dynamic 3D chromosomal landscapes in acute leukemia 0.67
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 0.66
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 0.66
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.65
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.65
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.64
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.64
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.64
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.63
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.63
Genome-wide discovery of human splicing branchpoints 0.63
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.63
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.63
RNA seq with AML (NB4) cells upon FTO inhibition 0.62
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.62
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.62
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.61
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.61
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.6
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.6
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.58
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.58
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.57
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.57
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.56
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.56
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.56
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.55
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.55
In vitro modeling of human germ cell development using pluripotent stem cells 0.55
JAK dependent survival of ALK- ALCL 0.55
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.55
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.54
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.54
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.53
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.53
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.53
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.53
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.52
Illumina Total RNA-seq in HeLa 0.52
CDK4/6 inhibitor resistance in prostate cancer 0.52
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.51
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.5
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.5
Pharmacologic inhibition of STAT5 in AML 0.49
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.49
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.49
Bone marrow derived human B cells [normal proB] 0.48
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.48
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.48
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.48
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.47
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.46
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.46
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 0.46
RNA-Seq of the corpus callosum from 12 individuals 0.46
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.45
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.45
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.44
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.43
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 0.43
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.42
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.42
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.4
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.4
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.39
RNA-sequencing in irradiated and normal A549 cells. 0.39
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.38
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.38
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 0.38
RNA sequencing of human pancreatic cancer cell lines 0.38
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.38
Gene expression profiling of leukemia cells following asparagine depletion 0.37
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.37
Searching for target genes of miR-508/509/506/514 in HCT116 cells 0.37
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.37
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.37
Expression analysis of the TAF1 syndrome 0.37
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.37
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.37
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.36
The pause-initiation limit restricts transcription activation in human cells 0.36
Oncogenic roles of ARID5B in T-ALL 0.36
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.36
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.36
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.35
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.35
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.35
Transcription elongation regulates genome 3D structure 0.35
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.34
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.34
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.34
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.34
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.34
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.34
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.34
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 0.33
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.32
Dysregulated immune system networks in war veterans with PTSD 0.32
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.31
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.31
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.31
Differential gene expression profiles in imatinib-resistant cell lines 0.31
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.31
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.3
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.3
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.3
Transcription control by the ENL YEATS domain in acute leukemia 0.3
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 0.3
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.3
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.3
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.29
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.29
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.29
Reprogrammed myeloid cell transcriptomes in NSCLC 0.29
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.28
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.28
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.28
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.28
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.27
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.27
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.27
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.27
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.26
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.26
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.26
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.25
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.24
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.24
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.23
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.23
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.23
Functional significance of the HIV-1 Tat signature amino acid residues 0.23
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.22
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.22
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.22
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.22
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.22
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.2
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.19
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.19
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.18
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.18
quanTIseq: quantifying immune contexture of human tumors 0.18
Microglia innatly develop within cerebral organoids 0.18
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.18
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.18
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.18
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.18
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.16
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.16
Leucegene: AML sequencing (part 6) 0.16
naive T cell heterogeneity after neonatal thymectomy 0.16
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.16
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.16
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.15
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.15
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.15
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.15
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.15
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.15
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.15
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.14
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.14
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.14
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.14
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.14
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.14
Analyses of T-ALL (COG study) 0.14
RNA sequencing of T-ALL (COG study) 0.14
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.14
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.13
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.13
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.13
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.12
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.11
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.11
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.11
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.11
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.1
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.1
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.1
Gene expression profiling in metabolically heterogeneous human lung tumors 0.1
Measure transcript integrity using RNA-seq data 0.1
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.1
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.1
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.09
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.09
Clinker: visualizing fusion genes detected in RNA-seq data 0.09
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.08
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.08
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.07
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.06
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.06
Transcriptomic analysis of frontal fibrosing alopecia 0.06
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.05
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.05
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.05
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.05
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.05
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.04
The role of m6A/m-RNA methylation in stress response regulation 0.03
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.03
Deep RNA sequencing of the human placental transcriptome 0.02
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.02
The role of the Calcium-Sensing receptor in colorectal cancer 0.02
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.01
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.01
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.01
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.01
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.0
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.0
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line -0.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] -0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation